Clinical Trials
Remote Symptom Monitoring and Acute Care Utilization in Advanced Cancer Trials
Stover et alCancers

In a secondary analysis of a randomized clinical trial involving patients with advanced cancer receiving phase I therapies, incorporating remote symptom monitoring (RSM) into specialist palliative care (SPC) did not reduce emergency department (ED) visits or hospitalizations over 6 months.
The study evaluated 100 patients (mean age 56 years, 63% female, median survival 221 days [95% CI 171, 271]), with 43 patients randomized to SPC alone and 57 randomized to SPC plus RSM. Over 6 months of follow-up, at least one ED visit occurred in 51% (22/43) of patients receiving SPC alone compared to 53% (30/57) receiving SPC+RSM (p = 0.58). Hospitalization rates were also similar between study arms, occurring in 42% (18/43) of SPC patients and 37% (21/57) of SPC+RSM patients (p = 0.56).
Pain and respiratory symptoms were the most common presenting complaints, accounting for 27% and 22% of ED visits and 29% and 22% of hospital admissions, respectively. The primary underlying etiologies for acute care encounters were disease progression (49% of ED visits, 58% of hospitalizations) and acute complications (26% of ED visits, 28% of hospitalizations). Evaluation by two independent reviewers determined that only 5% (4/84) of ED visits and 0% (0/57) of hospitalizations were potentially avoidable, highlighting that acute care events in this cohort were largely unavoidable and underscoring the need for novel strategies to support patients undergoing phase I oncology trials.
Key Takeaways
- Adding remote symptom monitoring to specialist palliative care did not reduce 6-month rates of emergency department visits (53% vs 51%, p = 0.58) or hospitalizations (37% vs 42%, p = 0.56) in patients with advanced cancer receiving phase I therapies.
- Acute care encounters were driven primarily by disease progression (49% of ED visits, 58% of hospitalizations) and acute complications (26% of ED visits, 28% of hospitalizations), with only 5% (4/84) of ED visits and 0% (0/57) of hospitalizations deemed avoidable.
Read the original sourceCancers
